ISSN - 0973-0958

Pediatric Oncall Journal

Risk Factors and Clinical Characteristics of Late-Onset Neonatal Hypocalcemia 01/23/2025 00:00:00 https://www.pediatriconcall.com/Journal/images/journal_cover.jpg

Risk Factors and Clinical Characteristics of Late-Onset Neonatal Hypocalcemia

Ahmad Shafat Tak1, Maheen Dar1, Iftikhar Ali1, Needa Dar2.
1Department of Pediatrics, Government medical college, Srinagar, India,
2Government medical college, Jammu, India.

ADDRESS FOR CORRESPONDENCE
Iftikhar Ali, Children's Hospital Bemina Srinagar, India.
Email: driftikharkoree@gmail.com
Abstract
Objective: The study aimed to investigate the clinical profile and risk factors associated with late-onset neonatal hypocalcemia, a condition affecting neonates after 72 hours of life, and to assess the role of maternal factors and neonatal health conditions.
Methodology: A prospective observational study was conducted over 18 months at a children's hospital in Srinagar, including 99 neonates diagnosed with late-onset hypocalcemia. Data were collected through clinical examinations and laboratory tests, including serum calcium, magnesium, phosphorus, vitamin D3, and parathyroid hormone levels.
Statistical analysis: Data was organized in a structured Excel spreadsheet and summarized using descriptive statistics (mean and standard deviation). Continuous variable distributions were visualized with histograms. Pearson correlation analysis was conducted to examine associations between variables. Statistical significance was assessed using predefined thresholds
Results: The cohort consisted of 52.5% females and 47.5% males, with most neonates (93%) between 3 to 7 days old. The mean serum calcium level was 6.13 ± 0.69 mg/dL, and 58.8% of neonates had vitamin D3 deficiency. A strong positive correlation (r = 0.51, p < 0.001) was observed between maternal and neonatal vitamin D3 levels.
Conclusion: Late-onset hypocalcemia is associated with maternal vitamin D deficiency, cesarean section delivery, and inadequate breastfeeding. Improving maternal vitamin D supplementation and promoting exclusive breastfeeding are essential strategies for reducing neonatal hypocalcemia.
 
Keywords
Neonatal Hypocalcemia, late-onset hypocalcemia, maternal vitamin-D.
 
Introduction
Neonatal late-onset hypocalcemia, typically occurring after the first 72 hours of life, is a significant clinical condition that can lead to seizures, irritability, and feeding difficulties in neonates. This condition arises from a complex interplay of metabolic, dietary, and environmental factors, often exacerbated by predisposing conditions like maternal diabetes, vitamin D deficiency, and preterm birth.1 Understanding these diverse risk factors is critical for early identification and effective management of late-onset hypocalcemia. Timely recognition and treatment of clinical manifestations are essential to prevent complications and support optimal growth and development in vulnerable neonates.
 
Methodology
This prospective observational study was conducted over 18 months in the Neonatal Division, Department of Pediatrics, at a 500-bedded Children's Hospital in Srinagar. The study aimed to investigate the clinical profile and risk factors associated with neonatal late-onset hypocalcemia. A total of 99 neonates with documented biochemical evidence of late-onset hypocalcemia admitted during the study period were included in this study. Neonates with early-onset hypocalcemia (presenting within 72 hours), genetic syndromes predisposing to hypocalcemia, or prior use of calcium supplements or medications affecting calcium metabolism were excluded.
After obtaining informed consent, detailed history and physical examinations were performed. Medical history, including prenatal, perinatal, and postnatal factors, was documented, and symptoms of hypocalcemia (e.g., jitteriness and irritability) were assessed. Biochemical parameters like ionized calcium, serum calcium, magnesium, phosphorus, alkaline phosphatase, vitamin D3, parathyroid hormone, and maternal vitamin D3 levels were measured, and nutritional intake was evaluated.

Ethical Clearance - The IRB of Government Medical College Srinagar granted ethical approval via
Reference no:- IRB/GMC-SGR/Pedia/869 Dated 27-0ct-2022, and informed consent was obtained from parents/guardians. the procedures adhered to the ethical guidelines of the Declaration of Helsinki

Operational definitions: The following values of the various laboratory investigations were taken as being within the normal range as per various guidelines.
Early onset Hypocalcemia (presenting within 72 hours of life), Late-onset Hypocalcemia ( presenting after 72 hrs)
DEFINITION;
Hypocalcemia is defined by different total serum calcium and ionized serum calcium cutoffs for preterm and term infants.

Table 1. Total serum calcium and ionized serum calcium cut-offs for preterm and term infants.
Gestation Total Serum Calcium Ionic Serum Calcium
Preterm <7 mg/dl (7.0-10 mg/dl) <4 mg/dl
Term <8 mg/dl (8.0-10.8 mg/dl) <4.8 mg/dl


Table 2. Statistical Analysis.
Parameter Normal Range Remarks
Serum Magnesium 1.5-2.6 mg/dL Normal range for magnesium levels
Serum Phosphorus 2.3-4.7 mg/dL Normal range for phosphorus levels
Serum Alkaline Phosphatase 90-273 U/L Normal range for alkaline phosphatase
Parathyroid Hormone (PTH) 15-68.3 pg/mL Normal range for PTH levels
Serum Vitamin D3    
- Deficient <50 nmol/L Vitamin D3 deficiency
- Insufficient 50-74 nmol/L Insufficient Vitamin D3 levels
- Sufficient 75-250 nmol/L Optimal Vitamin D3 levels
- Potential Toxification >250 nmol/L Risk of Vitamin D3 toxicity


Statistical analysis: Data was organized in a structured Excel spreadsheet and summarized using descriptive statistics (mean and standard deviation). Continuous variable distributions were visualized with histograms. Pearson correlation analysis was conducted to examine associations between variables. Statistical significance was assessed using predefined thresholds.
 
Results
In our study, 99 neonates with late-onset hypocalcemia were included. Out of these, 52.5% (n=52) were females, and 47.5% (n=47) were males. Most neonates, 68.7% (n=68), hailed from rural areas of Kashmir.
Clinically, irritability was the most common symptom, observed in 41.3% (n=41) of neonates, followed by abnormal body movements in 33.3% (n=33) and lethargy in 11.1%(n=11). Jittery movements were the most frequent clinical signs 62.6% (n=62), and 7.1% (n=7) of the neonates exhibited respiratory distress. Regarding maternal health, 2% of mothers were diagnosed with gestational diabetes mellitus (GDM), and 64.6% of deliveries were by cesarean section (LSCS). (Table 3)

Table 3. Characteristics of the study population.
Demographic   Frequency Percent
Gender Male 47 47.5%
  Female 52 52.5%
Age Group 3 - Days 45 45.5%
  4-7 Days 48 48.8%
  8-21 days 6 6.1%
Weight <2500 g 13 13.2%
  >2500 gm 86 86.8%
Area Rural 68 69.0%
  Urban 31 31.0%
Type Of Delivery LSCS 64 64.6%
  NVD 35 35.4%
Clinical Features      
Irritable   41 41.3%
Abnormal Body Movement   33 33.3%
Lethargy   11 11.1%
Decreased Feeding   9 9.1%
Fast Breathing   6 5.1%
Excess Cry   3 3.0%
Jittery   62 62.6%
Hypertonic   8 8.1%
Hypotonic   5 5.1%


Among the neonates in the study, just 15.2% (n=15) received exclusive breastfeeding, whereas nearly 85% (n=85) were fed formula alone or a combination of breast milk and formula.
The biochemical analysis of the study cohort revealed a mean serum calcium level of 6.13 ± 0.69 mg/dL, with values ranging from 4.0 to 7.20 mg/dL. Serum magnesium levels averaged 1.64 ± 0.4 mg/dL, with 35.4% (n=35) of neonates presenting low levels. The mean serum phosphorus level was 6.84 ± 1.27 mg/dL, with elevated levels observed in 60.6% (n=60) of cases. Low serum alkaline phosphatase levels were detected in 9.1% (n=9) of neonates, and reduced serum parathyroid hormone (PTH) levels were found in 41.4% (n=41), with an average PTH concentration of 39.09 ± 21.14 pg/mL. (Table 4).

Table 4. Biochemical parameters in the study group.
Laboratory Investigations Groups/Levels Frequency(n) Percent(%)
Serum Magnesium Levels Low 35 35.4%
  Normal 64 64.6%
Serum Phosphorus Levels Normal 31 31.3%
  High 60 60.6%
Serum Alkaline Phosphatase Low 9 9.1%
  Normal 90 90.9%
PTH Levels Normal 58 58.6%
  Low 41 41.4%
Maternal Vit. D3 Levels Deficient 41 41.3%
  Insufficient 21 21.2%
  Sufficient 37 37.5%
Neonate Vit. D3 Levels Deficient 58 58.8%
  Insufficient 21 21.2%
  Sufficient 20 20.0%


Neonatal vitamin D3 levels were found to be deficient in 58.8% (n=58), insufficient in 21.2% (n=21), and adequate in 20% (n=20) of cases, with a mean concentration of 35.35 ± 15.73 ng/mL. Maternal vitamin D3 levels were deficient in 41.3% (n=43), insufficient in 21.2% (n=21) and sufficient in 37.5% (n=35) with a mean level of 68.92 ± 29.50 ng/mL. A moderate to strong positive correlation (r = 0.51, p < 0.001) was observed between maternal and neonatal vitamin D3 levels, with mothers with low vitamin D3 levels having neonates with lower serum vitamin D3 levels, indicating that maternal vitamin D3 levels could be a predictor for neonatal vitamin D3 status and a risk factor for late-onset hypocalcemia.
 
Discussion
This study provides valuable insights into the characteristics and potential risk factors of late-onset hypocalcemia, emphasizing the role of demographic, clinical, and biochemical factors in its development. In our study, the majority of cases (n=68) 68.7% were from rural areas of Kashmir. In rural regions, inadequate prenatal care, nutritional deficiencies, and cultural factors significantly impact neonatal health.2 Maternal nutrition in these areas is often poor due to limited access to diverse foods and healthcare, leading to higher rates of maternal malnutrition, which adversely affects neonates, contributing to low birth weight, poor growth, and increased neonatal mortality.3
Our study revealed a high cesarean delivery rate (n=64) (64.6%), consistent with other studies that link cesarean births to an increased risk of neonatal hypocalcemia.4,5 The lack of hormonal changes associated with vaginal delivery, along with delayed breastfeeding initiation after cesarean births, may disrupt calcium homeostasis in neonates. Another significant finding was that only 15.2% (n=15) of neonates in the study were exclusively breastfed, while almost 85% (n=85) received formula alone or a mix of breast milk and formula. Previous studies have highlighted the importance of breastfeeding in enhancing calcium bioavailability and metabolic stability in neonates.6 The association between formula feeding and neonatal hypocalcemia has been noted in earlier research.7 Formula-fed infants tend to receive more calcium than breastfed infants because formula contains about twice the calcium of breast milk. However, fractional calcium absorption is lower in formula-fed infants.8
The laboratory findings from our study underscore several key factors contributing to neonatal hypocalcemia. Hypomagnesemia was observed in 35.4% of cases, consistent with existing research indicating that magnesium deficiency can complicate hypocalcemia treatment by impairing parathyroid hormone (PTH) secretion and action.9 Elevated phosphorus levels in 60.6% of cases suggest disruptions in the calcium-phosphorus-PTH axis, potentially reducing calcium bioavailability and complicating hypocalcemia.10 Additionally, low PTH levels in 41.4% of cases indicate functional immaturity of the parathyroid glands, highlighting the complexities of calcium regulation during the neonatal period.
Our study also found that Vitamin D deficiency was prevalent in both neonates (58.8%) and mothers (41.3%). This finding aligns with previous studies linking poor vitamin D status to an increased risk of neonatal hypocalcemia.11,12 The interdependence of maternal and neonatal vitamin D levels is evident, with a strong correlation (p <0.001) between the two, underscoring the importance of maternal supplementation during pregnancy, as supported by earlier research.13 Vitamin D deficiency during pregnancy is a growing concern, affecting up to 50% of pregnant women globally. Since the fetus relies on the mother for vitamin D, supplementation during pregnancy can enhance maternal vitamin D levels and improve availability to the fetus and neonate. Vitamin D supplementation is crucial for exclusively breastfed infants, as breast milk alone typically contains inadequate levels of vitamin D, which is essential for bone health and calcium absorption.14
This study emphasizes the importance of comprehensive prenatal care, particularly the routine screening and supplementation of vitamin D for pregnant women. Addressing rural healthcare disparities, promoting vaginal deliveries, and supporting exclusive breastfeeding are crucial measures to reduce the risk of neonatal hypocalcemia. These efforts are essential for enhancing neonatal health and preventing complications associated with this condition.
 
Conclusion
Late-onset hypocalcemia is associated with maternal vitamin D deficiency, cesarean section delivery, and inadequate breastfeeding. Improving maternal vitamin D supplementation and promoting exclusive breastfeeding are essential strategies for reducing neonatal hypocalcemia.

Limitation: relatively small sample size (99 neonates), which may limit the generalizability of the findings, and the lack of long-term follow-up to assess the impact of late-onset hypocalcemia on neonatal development.
 
Compliance with Ethical Standards
Funding None
 
Conflict of Interest None
 
  1. Zivin JR, Gooley T, Zager RA, Ryan MJ. Hypocalcemia: a pervasive metabolic abnormality in the critically ill. Am J Kidney Dis. 2001;37(4):689-98.  [CrossRef]  [PubMed]
  2. Borkenhagen JF, Eastwood DC, Kilari AS, Maloney SK, Tran BL, Suh DY, et al. A rural-urban comparison of neonatal intensive care unit services. J Rural Health. 2018;34(s1):s39-s47.
  3. Black RE, Victora CG, Walker SP, Bhutta ZA, Christian P, de Onis M, et al.; Maternal and Child Nutrition Study Group. Maternal and child undernutrition and overweight in low-income and middle-income countries. Lancet. 2013;382(9890):427-51. doi:10.1016/S0140-6736(13)60937-X.  [CrossRef]  [PubMed]
  4. Cordero L, Treuer SH, Landon MB, Gabbe SG. Management of infants of diabetic mothers. Arch Pediatr Adolesc Med. 1998;152(3):249-54.  [CrossRef]  [PubMed]
  5. Loughead JL, Mimouni F, Tsang RC. Serum ionized calcium concentrations in normal neonates. Am J Dis Child. 1988;142(5):516-8.  [CrossRef]  [PubMed]
  6. Gartner LM, Morton J, Lawrence RA, Naylor AJ, O'Hare D, Schanler RJ, et al. Breastfeeding and the use of human milk. Pediatrics. 2005;115(2):496-506.  [CrossRef]  [PubMed]  [PMC free article]
  7. Fomon SJ, Nelson SE. Calcium, phosphorus, magnesium, and sulfur. In: Fomon SJ. Nutrition of normal infants. St. Louis: Mosby-Year Book; 1993. p. 192-216.
  8. Rude RK, Singer FR, Gruber HE. Skeletal and hormonal effects of magnesium deficiency. J Am Coll Nutr. 2009;28(2):131-41.  [CrossRef]  [PubMed]
  9. Salle BL, Delvin EE, Lapillonne A, Bishop NJ, Glorieux FH. Perinatal metabolism of vitamin D. Am J Clin Nutr. 2000;71(5 Suppl):1317S-24S.  [CrossRef]  [PubMed]
  10. Dawodu A, Wagner CL. Mother-child vitamin D deficiency: an international perspective. Arch Dis Child. 2007;92(9):737-40.  [CrossRef]  [PubMed]  [PMC free article]
  11. Nutrition. Prevention of rickets and vitamin D deficiency in infants, children, and adolescents. Pediatrics. 2008;122(5):1142-52.  [CrossRef]  [PubMed]
  12. Bowyer L, Catling-Paull C, Diamond T, Homer C, Davis G, Craig ME. Vitamin D, PTH and calcium levels in pregnant women and their neonates. Clin Endocrinol (Oxf). 2009;70(3):372-7.  [CrossRef]  [PubMed]
  13. Merewood A, Mehta SD, Chen TC, Bauchner H, Holick MF. Association between vitamin D deficiency and primary cesarean section. J Clin Endocrinol Metab. 2009;94(3):940-5.  [CrossRef]  [PubMed]  [PMC free article]
  14. Heo JS, Ahn YM, Kim AE, Shin SM. Breastfeeding and vitamin D. Clin Exp Pediatr. 2022;65(9):418-29. doi:10.3345/cep.2021.00444.  [CrossRef]  [PubMed]  [PMC free article]



DOI: https://doi.org/10.7199/ped.oncall.2026.56

Cite this article as:
Tak A S, Dar M, Ali I, Dar N. Risk Factors and Clinical Characteristics of Late-Onset Neonatal Hypocalcemia. Pediatr Oncall J. 2025 Sep 17. doi: 10.7199/ped.oncall.2026.56
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License
Disclaimer: The information given by www.pediatriconcall.com is provided by medical and paramedical & Health providers voluntarily for display & is meant only for informational purpose. The site does not guarantee the accuracy or authenticity of the information. Use of any information is solely at the user's own risk. The appearance of advertisement or product information in the various section in the website does not constitute an endorsement or approval by Pediatric Oncall of the quality or value of the said product or of claims made by its manufacturer.
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0